StageIncubator/Accelerator | Alive
NuEyes operates as an augmented reality (AR) smart glass technology company. It develops electronic smart glasses for the visually impaired and aims to assist those suffering from eye conditions such as macular degeneration, glaucoma, and retinitis pigmentosa, via a mobile, wireless, and lightweight solution. The company was founded in 2016 and is based in Newport Beach, California.
Missing: NuEyes's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: NuEyes's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing NuEyes
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
NuEyes is included in 3 Expert Collections, including Medical Devices.
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)
Latest NuEyes News
Sep 7, 2022
NuEyes is pairing its PRO Series Smart Glasses with Samsung 5G connected devices to provide clinicians with a hands-free, virtual experience. NuEyes ultrasound. Image courtesy of NuEyes Technologies Inc. Michael Barbella, Managing Editor09.07.22 NuEyes Technologies Inc . is teaming up with Samsung Electronics America to deliver healthcare solutions through smart glasses. NuEyes Technologies PRO Series Augmented Reality smartglasses are lightweight glasses with a binocular display that quickly and easily connects to Samsung5G mobile phones or tablets. With a large field of view, HD display, and weighing under 130 grams, the NuEyes glasses are a portable solution for common healthcare functions such as ultrasound imaging, remote medicine, on-the-job support, training in the hospitals, universities, or out in the field. Powered by Samsung's 5G Galaxy S Series mobile phones and tablets, medical professionals can now access live video, remote specialists, and imaging from anywhere to help improve patient care. Samsung 5G connected devices paired with the NuEyes PRO Series Smart Glasses provide medical practitioners a portable, hands-free, always connected experience. The alliance between Samsung and NuEyes Technologies will continue to advance the medical industry and bring the promise of the metaverse closer. "At NuEyes we are focused on delivering solutions that enhance patient care, whether that is through our low vision solutions or with a medical practitioner delivering care," said Mark Greget, founder and CEO of NuEyes Technologies Inc. "Partnering with Samsung Healthcare allows us to expand our reach and deliver solutions that will help advance the medical industry and patient care." Samsung operates one of the most advanced medical centers in the world, located in Suwon, Korea, and applies that expertise in developing digital healthcare solutions that drive staff productivity and improve patient experience in hospitals, at home, and through virtual care. The Samsung platform empowers providers with smart technologies through a connected ecosystem of secure mobile devices and signage that are easy to manage and transition seamlessly across clinical workflows. Enhance patient care, streamline critical communications, and raise the visibility of your brand with Samsung advanced, digital solutions for healthcare. NuEyes is a veteran-owned smart glass technology company based in Orange County, California, that was launched in January 2016 to assist those with eye conditions such as macular degeneration, glaucoma, and retinitis pigmentosa. Over the past five years, the company has seen extensive sales growth and obtained federal, state, and insurance reimbursement for its devices. NuEyes addresses a multitude of augmented reality markets including low vision and medical, enterprise, gaming, and entertainment.
NuEyes Frequently Asked Questions (FAQ)
When was NuEyes founded?
NuEyes was founded in 2016.
Where is NuEyes's headquarters?
NuEyes's headquarters is located at 120 Newport Center Drive, Newport Beach.
What is NuEyes's latest funding round?
NuEyes's latest funding round is Incubator/Accelerator.
Who are the investors of NuEyes?
Investors of NuEyes include MassChallenge and Arab Angel Fund.
Who are NuEyes's competitors?
Competitors of NuEyes include eSight and 1 more.
Compare NuEyes to Competitors
OrCam Technologies offers a computer vision device that includes a miniature video camera and processing unit that can be attached to eyeglasses. Through a computer vision algorithm, the device is able to vocalize texts it encounters, such as street signs, a restaurant menu, a newspaper, or a book, to those with vision problems. It can identify supermarket products and distinguish different denominations of bills. The identification is communicated to the user verbally with almost no delay from the moment the information is requested by pointing. It can be clipped to a belt or placed into a pocket, and it needs to be kept charged.
Direct Flow Medical is focused on developing novel transcatheter heart valve technologies that improve patient outcomes while reducing patient complications. The company is exploring application of its proprietary technology beyond the aortic valve, to the mitral valve and other valve anatomy. Headquartered in Santa Rosa, California, the company also has technology and manufacturing facilities in Lake Forest, California.
BioResonator aims to measure eye pressure with the resonance frequency.
OcuSciences is developing a product to use images from the eye to detect diseases such as diabetes at an earlier stage.
Realistic Eye aims to provide a more natural appearance for the 750,000 patients in the US with an artificial eye that does not dilate and therefore appears unnatural. RealisticEye achieves these results by introducing a dilating artificial eye.
IrisVision develops VR technology for the visually impaired. The company aims to relieve macular degeneration, diabetic retinopathy, Stargardt disease, Retinitis Piigmentosa, glaucoma, and ocular albinism.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.